Magnetic Seizure Therapy (MST) for Severe Mood Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Depression
Interventions
DEVICE

Thymatron

Right unilateral placement, 6x seizure threshold, 3 times per week until clinically appropriate to stop (approximately 2-6 weeks)

DEVICE

Magstim Theta

100% power, vertex placement, 3 times per week, until clinically appropriate to stop (approximately 2-6 weeks)

Trial Locations (2)

27710

Duke University, Durham

75390

University of Texas Southwestern Medical Center, Dallas

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Duke University

OTHER

collaborator

University of Texas Southwestern Medical Center

OTHER

collaborator

Stanley Medical Research Institute

OTHER

lead

Sarah Lisanby

OTHER

NCT00488748 - Magnetic Seizure Therapy (MST) for Severe Mood Disorder | Biotech Hunter | Biotech Hunter